(1,4-Diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone Ligands for Nicotinic Acetylcholine Receptors, Useful for the Treatment of Disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100298306A1
SERIAL NO

12739040

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds, which act as ligands for the α7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof. The novel compounds include compounds of formula I:are as herein defined.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEMORY PHARMACEUTICALS CORPORATION100 PHILIPS PARKWAY MONTVALE NJ 07645

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dai, Guangxiu Baton Rouge, US 22 61
Herbert, Brian Stockholm, US 30 507
Schumacher, Richard Monroe, US 34 692
Xie, Wenge Mahwah, US 38 556

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation